Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

Bloomberg News Now

Trump: Iran Ceasefire is Weakened, Oil Climbs on Iran Deadlock, More

12 May 2026

Transcription

Transcript generated automatically by AI and may contain errors.

Chapter 1: What is the main topic discussed in this episode?

0.672 - 5.121 Stephen Carroll

Hello, I'm Stephen Carroll. I'm in Brussels, where many of Europe's biggest decisions get made.

0

5.622 - 10.011 Caroline Hepke

And I'm Caroline Hepke in London. We're the hosts of the Bloomberg Daybreak Europe podcast.

0

10.391 - 15.001 Stephen Carroll

We're up early every weekday, keeping an eye on what's happening across Europe and around the world.

0

15.422 - 21.634 Caroline Hepke

We do it early so the news is fresh, not recycled, and so you know what actually matters as the day gets going.

0

21.698 - 27.166 Stephen Carroll

From Brussels, I'm following the politics, policy and the people shaping the European Union right now.

27.206 - 32.633 Caroline Hepke

And from London, I'm looking at what all that means for markets, money and the wider economy.

33.154 - 37.48 Stephen Carroll

We've got reporters across Europe and around the globe feeding in as stories break.

37.941 - 42.587 Caroline Hepke

So whether it's geopolitics, energy, tech or markets, you're hearing it while it happens.

43.028 - 45.03 Stephen Carroll

It's smart, calm and to the point.

Chapter 2: What is the current status of the U.S.-Iran ceasefire?

275.947 - 291.27 Dan Schwartzman

President Trump is expected to press Chinese President Xi Jinping over China's approach to Iran and hammer out details on a new border trade when they meet this week in Beijing. And the White House is inviting executives from large companies to accompany President Trump on his trip to China.

0

291.61 - 308.695 Tom Busby

Bloomberg's Tom Busby with more. Elon Musk of Tesla and SpaceX AI, along with Apple's Tim Cook and Boeing's Kelly Ortberg, the latest CEOs slated to accompany President Trump to a summit with China's Xi Jinping this week, hoping to open up multi-billion dollar business deals and purchase agreements with Beijing.

0

308.675 - 327.814 Tom Busby

Now, already confirmed, the chief executives of Goldman Sachs, BlackRock, Citigroup, GE, Cargill, Micron Technology, and others. Noticeably absent, though, Jensen Huang of NVIDIA, a potential setback for his bid to export AI chips to China, a market that Huang said could top $50 billion in sales. Tom Busby, Bloomberg Radio.

0

327.794 - 347.473 Dan Schwartzman

And White House Deputy Press Secretary Anna Kelly tells Fox News that aerospace, energy and agriculture deals can be expected to come from President Trump's meeting with Chinese President Xi Jinping. The Trump administration asked the U.S. Trade Court to pause a ruling that declared the president's latest 10 percent global tariffs unlawful while the government appeals.

0

347.453 - 367.644 Dan Schwartzman

In a two-to-one decision last week, a U.S. Court of International Trade panel found that President Trump's use of Section 122 of the Trade Act of 1974 to impose the tariffs was invalid, although the court only immediately blocked enforcement for two companies that sued, along with Washington state. The government's appeal of that decision is pending before the U.S.

367.664 - 385.526 Dan Schwartzman

Court of Appeals for the Federal Circuit. with the administration poised to make an emergency request to the Supreme Court if necessary. Virginia has asked the Supreme Court to restore its voting map, which was voided last week by the Virginia Supreme Court. It may be a long shot, though, as the U.S. Supreme Court intervenes only on issues of federal law.

386.006 - 402.385 Dan Schwartzman

And the Supreme Court is leaving women's access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug. Hims and Hers Health reported a first quarter loss in sales that missed Wall Street estimates. More details from Bloomberg's Charlie Pellett.

402.415 - 415.813 Brian Tanquelet

The company has been moving away from copycat versions of weight loss medications that help fuel its growth, instead prioritizing partnerships with brand name products. Brian Tanquelet is research analyst at Jefferies.

416.033 - 428.452 Unknown

What happened was that earlier this year, HIMSS signed an agreement with Novo Nordisk to basically say we're going to stop compounding or making our own versions of GLPs. and we're just going to distribute a Novo Nordisk brand.

Comments

There are no comments yet.

Please log in to write the first comment.